Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America.

Autor: Bloom MW; Division of Cardiology, NYU Langone Health, NYU Grossman School of Medicine, New York, NY. Electronic address: michelle.bloom@nyulangone.org., Vo JB; Radiation Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, MD., Rodgers JE; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC., Ferrari AM; Division of Hematology/ Oncology, University of Virginia Health, Charlottesville, VA., Nohria A; Cardio-Oncology Program, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA., Deswal A; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, TX., Cheng RK; Division of Cardiology, University of Washington, Seattle, WA., Kittleson MM; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA., Upshaw JN; Division of Cardiology, Tufts Medical Center, Boston, MA., Palaskas N; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Blaes A; Division of Hematology/Oncology/Transplantation, University of Minnesota, Minneapolis, MN., Brown SA; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Research Collaborator, Mayo Clinic, Rochester, MN., Ky B; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Thalheimer Center for Cardio-Oncology, Abramson Cancer Center and Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Lenihan D; Saint Francis Healthcare, Cape Girardeau, MO and the International Cardio-Oncology Society, Tampa, FL., Maurer MS; Division of Cardiology, Columbia University Irving Medical Center, New York, NY., Fadol A; MD Anderson Cancer Center, Houston, TX., Skurka K; Cardio-Oncology Nurse/Program Consultant., Cambareri C; Clinical Oncology Pharmacist, Hospital of the University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA., Chauhan C; Patient Advocate., Barac A; Department of Cardiology, Inova Schar Heart and Vascular, Inova Schar Cancer, Falls Church, VA.

Publikováno v: Journal of cardiac failure [J Card Fail] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Kinase Inhibitors and Atrial Fibrillation: Mechanisms of Action and Clinical Implications.

Autor: Potter AS; Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA; Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, USA., Hulsurkar MM; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA; Department of Integrative Physiology, Baylor College of Medicine, Houston, Texas, USA., Wu L; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA., Narasimhan B; Department of Cardiology, Houston Methodist Hospital, Houston, Texas, USA., Karimzad K; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Koutroumpakis E; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Palaskas N; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Deswal A; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantharia BK; Cardiovascular and Heart Rhythm Consultants & Icahn School of Medicine at Mount Sinai, New York, New York, USA., Wehrens XHT; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA; Department of Integrative Physiology, Baylor College of Medicine, Houston, Texas, USA; Department of Medicine (in Cardiology), Baylor College of Medicine, Houston, Texas, USA; Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Center for Space Medicine, Baylor College of Medicine, Houston, Texas, USA. Electronic address: wehrens@bcm.edu.

Publikováno v: JACC. Clinical electrophysiology [JACC Clin Electrophysiol] 2023 Apr; Vol. 9 (4), pp. 591-602. Date of Electronic Publication: 2023 Feb 22.

Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry.

Autor: Nowatzke J; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Guedeney P; Sorbonne Université, Department of Cardiology, INSERM UMRS_1166, Pitié Salpêtrière (AP-HP), Paris, France., Palaskas N; Department of Cardiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Lehmann L; Department of Cardiology, University Hospital of Heidelberg, 69120, Heidelberg, Germany; Institute of Experimental Cardiology, University Hospital of Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site, Heidelberg/Mannheim, Germany., Ederhy S; Department of Cardiology, UNICO Cardio-Oncology Program, INSERM U 856, Hôpital Saint-Antoine, AP-HP, Paris, France., Zhu H; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA., Cautela J; French Institute of Health and Medical Research 1263, National Institute of Agricultural Research, Centre for CardioVascular and Nutrition Research, Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, University Mediterranean Centre of Cardio-Oncology, Nord Hospital, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille University, Marseille, France., Francis S; Cardiovascular Disease Service Line, Maine Medical Center, Portland, ME, USA., Courand PY; Fédération de Cardiologie, Hôpital de La Croix-Rousse et Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France; Université de Lyon, CREATIS, CNRS UMR5220, INSERM U1044, INSA-Lyon, Université Claude Bernard Lyon 1, France., Deswal A; Department of Cardiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Ewer SM; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., Aras M; Division of Cardiology, University of California-San Francisco, San Francisco, CA, USA., Arangalage D; Department of Cardiology, Bichat Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Université de Paris, UMRS1148, INSERM, Paris, France; Université de Paris, Paris, France., Ghafourian K; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Fenioux C; Department of Pharmacology and Clinical Investigation Centre (CIC-1901), Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, 75013, Paris, France., Finke D; Department of Cardiology, University Hospital of Heidelberg, 69120, Heidelberg, Germany; Institute of Experimental Cardiology, University Hospital of Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site, Heidelberg/Mannheim, Germany., Peretto G; Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Scientific Institute, Vita-Salute University and San Raffaele Hospital, Via Olgettina 60, 20132, Milan, Italy., Zaha V; Division of Cardiology, Department of Internal Medicine, Cardio-Oncology Program, Harold C. Simmons Comprehensive Cancer Center, Advanced Imaging Research Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Itzhaki Ben Zadok O; Heart Failure Unit, Cardiology Department, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Tajiri K; Department of Cardiology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan., Akhter N; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Levenson J; Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Baldassarre L; Yale School of Medicine, New Haven, CT, USA., Power J; Division of Cardiovascular Medicine, University of California San Diego, San Diego, CA, USA., Huang S; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Collet JP; Sorbonne Université, Department of Cardiology, INSERM UMRS_1166, Pitié Salpêtrière (AP-HP), Paris, France., Moslehi J; Division of Cardiology, University of California-San Francisco, San Francisco, CA, USA. Electronic address: javid.moslehi@ucsf.edu., Salem JE; Department of Pharmacology and Clinical Investigation Centre (CIC-1901), Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, 75013, Paris, France. Electronic address: joe-elie.salem@aphp.fr.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Dec; Vol. 177, pp. 197-205. Date of Electronic Publication: 2022 Aug 24.

Post-cardiac arrest PCI is underutilized among cancer patients: Machine learning augmented nationally representative case-control study of 30 million hospitalizations.

Autor: Kim JW; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA. Electronic address: jin.wan.kim@uth.tmc.edu., Monlezun D; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Park JK; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Chauhan S; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Balanescu D; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Koutroumpakis E; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Palaskas N; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kim P; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hassan S; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Botz G; Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Crommett J; Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reddy D; Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cilingiroglu M; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Marmagkiolis K; Pepin Heart Institute Florida Hospital, Tampa, FL, USA., Iliescu C; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: Resuscitation [Resuscitation] 2022 Oct; Vol. 179, pp. 43-49. Date of Electronic Publication: 2022 Aug 04.